Study Finds Basic Handwriting Tasks Show Little Difference in Older Adults With or Without Cognitive Impairment
A study of 58 adults aged 62 to 92 found dictation tasks exposed differences in writing speed and coordination between those with and without cognitive impairment.
Fox NewsResearchers in Portugal found that dictation writing tasks revealed slower, more fragmented and less coordinated patterns among older adults with cognitive impairment compared with those without such diagnoses. The study included 58 adults between the ages of 62 and 92 living in care homes. Thirty-eight of the participants had already been diagnosed with cognitive impairment.
Participants completed writing exercises on a specialized digital tablet that recorded precise hand movements while they used an ink pen. The exercises included basic pen control, copying sentences from a flashcard, and writing sentences spoken aloud. Simple tasks such as drawing lines or copying text showed no major differences between the two groups.
In contrast, dictation tasks produced clear distinctions. Adults with cognitive impairment took longer to begin writing, paused more often and had greater difficulty organizing strokes when writing from dictation. "Dictation tasks are more sensitive because they require the brain to do multiple things at once: listen, process language, convert sounds into written form and coordinate movement," Dr.
Ana Rita Matias, the study's senior author from the University of Évora, stated in a press release. Matias said the long-term goal is to develop a tool that is easy to administer, time-efficient and affordable, allowing integration into everyday healthcare contexts without requiring specialized or expensive equipment. The study was published in Frontiers in Human Neuroscience.
It did not account for participants' use of medications. Currently, diagnosing cognitive decline often involves expensive brain scans or lengthy psychological testing. The researchers noted that larger and more diverse groups need to be tested to confirm the findings.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
New ScientistPhase 3 Trial Finds Daraxonrasib Extends Median Survival to 13 Months vs 7 Months for Chemotherapy in Second-Line Pancreatic Cancer
A 500-person study found the once-daily pill halted or reversed tumor progression in nearly one-third of patients versus 10 percent on chemotherapy. Median survival rose from less than seven months to roughly 13 months.
nypost.comBundibugyo Ebola Strain Shows High Survival Rate in DRC; Suspected Cases Reported in Brazil and Italy
Four nurses and one laboratory worker have recovered from Ebola caused by the Bundibugyo strain in the Democratic Republic of Congo. Suspected cases linked to travel from affected countries are under investigation in Brazil and Italy.
Wildfire Insured Losses Hit $54 Billion in 2025, Highest on Record
A new analysis published Sunday found that insured losses from wildfires worldwide hit at least $54 billion in 2025, the highest level on record. The Los Angeles fires and blazes in South Korea and Spain drove the total.